SEC Form 4 · accession 0001104659-15-039019
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas J. Lowery
Officer — Chief Scientific Officer
Period of report
May 4, 2015
Accepted (ET)
May 18, 2015 · 3:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 4, 2015 | M | 1,000 | $1.16 | A | 6,882 | D | |
| Common Stock | May 4, 2015 | S | 1,000 | $16.00 | D | 5,882 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.16 | May 4, 2015 | M | 1,000 | A | Feb 27, 2013 | Feb 27, 2019 | Common Stock | 1,000 | 21,529 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2015.